← Back to directory

Tom Eirik Mollnes

Researcher Next ID · RN-038194

Researcher · Immunology and Microbiology

Oslo University Hospital

Oslo, Norway

Accepting doctoral researchersFunding unknown
Works count
691
Citation count
22,369
H-index
73
i10-index
392

Research interests

Immunology and Microbiology
Medicine
Complement system in diseases
Immune Response and Inflammation
Blood Coagulation and Thrombosis Mechanisms
Blood groups and transfusion
Platelet Disorders and Treatments

Publications

  • Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation

    Science Immunology · 2021 · 10.1126/sciimmunol.abf2489

  • Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics

    Pharmacological Reviews · 2021 · 10.1124/pharmrev.120.000072

  • Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

    Proceedings of the National Academy of Sciences · 2020 · https://doi.org/10.1073/pnas.2010540117

  • The Role of Complement in Liver Injury, Regeneration, and Transplantation

    Hepatology · 2019 · 10.1002/hep.30508

  • Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions

    ACS Nano · 2019 · 10.1021/acsnano.9b03942

  • Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population

    Frontiers in Immunology · 2018 · 10.3389/fimmu.2018.02664

  • Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes

    Nature Nanotechnology · 2017 · 10.1038/nnano.2017.47

  • Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation

    Mucosal Immunology · 2016 · 10.1038/mi.2016.18

  • Cholesterol Crystals Induce Complement-Dependent Inflammasome Activation and Cytokine Release

    The Journal of Immunology · 2014 · 10.4049/jimmunol.1302484

  • An international serum standard for application in assays to detect human complement activation products

    Molecular Immunology · 2013 · 10.1016/j.molimm.2013.05.221

  • Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis

    Blood · 2010 · 10.1182/blood-2010-02-269746

  • The Rab11a GTPase Controls Toll-like Receptor 4-Induced Activation of Interferon Regulatory Factor-3 on Phagosomes

    Immunity · 2010 · 10.1016/j.immuni.2010.09.010

  • Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study

    European Respiratory Journal · 2009 · 10.1183/09031936.00088209

  • Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis

    Scandinavian Journal of Immunology · 2009 · 10.1111/j.1365-3083.2009.02255.x

  • The alternative complement pathway revisited

    Journal of Cellular and Molecular Medicine · 2008 · 10.1111/j.1582-4934.2008.00350.x

  • Complement and coagulation: strangers or partners in crime?

    Trends in Immunology · 2007 · 10.1016/j.it.2007.02.006

  • The role of complement in biomaterial-induced inflammation

    Molecular Immunology · 2006 · 10.1016/j.molimm.2006.06.020

  • Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA

    Journal of Immunological Methods · 2004 · 10.1016/j.jim.2004.11.016

  • The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation

    Clinical & Experimental Immunology · 2004 · 10.1111/j.1365-2249.2004.02627.x

  • Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.

    PubMed · 2002 · 10.1182/blood.v100.5.1869.h81702001869_1869_1877

  • Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.

    Journal of Clinical Investigation · 1995 · 10.1172/jci117751

  • Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations

    Journal of Thoracic and Cardiovascular Surgery · 1992 · 10.1016/s0022-5223(19)34966-9

  • Complement-Mediated Demyelination in Patients with IgM Monoclonal Gammopathy and Polyneuropathy

    New England Journal of Medicine · 1990 · 10.1056/nejm199003083221002

  • Complement Activation and Endotoxin Levels in Systemic Meningococcal Disease

    The Journal of Infectious Diseases · 1989 · 10.1093/infdis/160.1.58

  • Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the Complex

    Scandinavian Journal of Immunology · 1985 · 10.1111/j.1365-3083.1985.tb01871.x

Current projects

    No projects listed.